Verily is on the up-and-up—as in, re-upping a team-up with the Crohn’s & Colitis Foundation to help spur research into inflammatory bowel disease (IBD) forward. Alphabet’s life sciences arm announced ...
Alphabet's life science subsidiary Verily announced a strategic restructuring last year, shifting its focus to using AI and data science to improve precision health options. Andrew Trister, chief ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results